Seven novel modulators of the analgesic target NaV 1.7 uncovered using a high-throughput venom-based discovery approach.
Klint, J.K., Smith, J.J., Vetter, I., Rupasinghe, D.B., Er, S.Y., Senff, S., Herzig, V., Mobli, M., Lewis, R.J., Bosmans, F., King, G.F.(2015) Br J Pharmacol 172: 2445-2458
- PubMed: 25754331 
- DOI: 10.1111/bph.13081
- Primary Citation of Related Structures:  
2MPQ - PubMed Abstract: 
Chronic pain is a serious worldwide health issue, with current analgesics having limited efficacy and dose-limiting side effects. Humans with loss-of-function mutations in the voltage-gated sodium channel NaV 1.7 (hNaV 1.7) are indifferent to pain, making hNaV 1 ...